Article
Clinical features combined with ultrasound characteristics to predict TERT promoter mutations in papillary thyroid carcinoma: a single-center study over the past 5 years.
Frontiers in endocrinology - 1 Jan 2024
Hu Yan, Xu Shangyan, Dong Lei, Pan Zuxian, Zhang Lu, Zhan Weiwei
Abstract excerpt
Purpose: Telomerase reverse transcriptase (TERT) has been reported in papillary thyroid carcinoma (PTC). This study aimed to investigate the correlation of TERT promoter mutations with clinical and ultrasound (US) features in PTC and to develop a model to predict TERT promoter mutations. Methods: Preoperative US images, postoperative pathological features, and TERT promoter mutation information were evaluated in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
